Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

The Big Picture: Between G7 and G20 meetings, traders wary of possible currency wars

Friday, February 15, 2013

amb
John Butler
An Opalesque column for global macro investors.

Benedicte Gravrand, Opalesque Geneva:

There was some confusion earlier this week on the message the G7 wanted to convey on foreign exchange rates after their meeting. As there was no mention of the yen, the markets continued speculating and the yen further depreciated. The G7 subsequently issued another statement saying, "The G7 statement signalled concern about excess moves in the yen. The G7 is concerned about unilateral guidance on the yen. Japan will be in the spotlight at the G20 in Moscow this weekend." The yen rallied after the statement.

"Rather than calm the markets, the poorly communicated statement has significantly raised volatility," Richard Gilhooly, fixed-income strategist at TD Securities in New York, told Reuters. The yen went from 78 to a dollar in early October 2012 to 92.88 yesterday, after peaking to 94.32 on Monday (11 February, 2013).

G20 finance ministers and central bankers are meeting in Moscow today and tomorrow (15/16 Feb - the main summit will take place in September). Bank of Canada’s chief Mark Carney said the G7 (the U.S., Britain, France, Germany, Japan, Canada and Italy) should, during the G20 meeting, urge developing countries to adopt flexible exchange rates ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its